Skip to main content
NRIX logo
NRIX
(NASDAQ)
Nurix Therapeutics, Inc.
$15.51-- (--)
Loading... - Market loading

Nurix Therapeutics (NRIX) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Nurix Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Nurix Therapeutics, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingNov 2025Nov 2024Nov 2023Nov 2022Nov 2021Nov 2020Nov 2019Nov 2018
Revenue & Gross Profit
Revenue83.9854.5576.9938.6329.7517.8231.1237.45
Cost of Revenue18.86221.63189.15184.50116.4366.4945.0340.51
Gross Profit65.12-167.08-112.16-145.87-86.68-48.67-13.91-3.07
Operating Expenses
Research & Development308.16221.63189.15184.50116.4366.4945.0340.51
Selling, General & Administrative52.7445.9442.9038.0031.2016.318.336.67
Operating Expenses350.7945.94232.0538.0031.2016.318.336.67
Operating Income-285.67-213.03-155.06-183.87-117.89-64.98-22.24-9.74
Other Income/Expense
Interest Income21.9719.7311.123.510.821.210.780.82
Interest Expense0.000.000.000.000.000.000.000.00
Other Income/Expense21.9719.7311.123.510.821.210.780.82
Income
Income Before Tax-263.70-193.30-143.95-180.36-117.06-63.78-21.46-8.92
Income Tax Expense0.760.270.000.000.13-20.540.240.51
Net Income-264.46-193.57-143.95-180.36-117.19-43.24-21.70-9.43
Net Income - Continuous Operations-264.46-193.57-143.95-180.36-117.19-43.24-21.70-9.43
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA-244.84-196.60-141.41-173.06-115.90-62.80-19.88-6.75
EBIT-285.67-213.03-155.06-183.87-117.890.000.000.00
Depreciation & Amortization18.868.0213.654.151.992.182.352.99
Earnings Per Share
Basic EPS-3.00-3.00-3.00-4.00-3.00-3.00-1.00-1.00
Diluted EPS-3.00-3.00-3.00-4.00-3.00-3.00-1.00-1.00
Basic Shares Outstanding86.6767.1254.3448.6142.9015.6738.8516.11
Diluted Shares Outstanding86.6767.1254.3448.6142.9015.6738.8516.11

Frequently Asked Questions About Nurix Therapeutics Financial Statements

What is an income statement?

An income statement shows a company's revenues, expenses, and net income over a specific period. It reveals profitability by starting with revenue and subtracting costs to arrive at net income — the "bottom line" that shows how much the company earned.

What is NRIX's revenue trend?

Review Nurix Therapeutics's quarterly and annual revenue figures in the income statement table above to identify growth trends, seasonal patterns, and year-over-year changes.

What is gross margin?

Gross margin is revenue minus cost of goods sold, expressed as a percentage. It shows how efficiently a company produces its goods or services. Higher gross margins indicate stronger pricing power and lower production costs.

What is operating income?

Operating income (EBIT) is revenue minus operating expenses, excluding interest and taxes. It measures a company's core business profitability before financing costs and tax effects, making it useful for comparing companies with different capital structures.

What is earnings per share (EPS)?

EPS divides net income by outstanding shares, showing the profit attributable to each share. Diluted EPS includes potential shares from stock options and convertible securities, providing a more conservative measure of per-share earnings.